checkpoints/clf_phase2b_fda_newsletter/ner_val.jsonl

{"id": "7d5a32abf2dd", "text": "However, swollen testes was reported in this study as one of the side effects of ACT.", "entities": [{"start": 9, "end": 23, "label": "ADR", "text": "swollen testes"}], "input_ids": [2, 2406, 16, 23561, 16880, 1982, 2568, 1922, 2052, 2161, 1966, 2340, 1927, 1920, 4159, 2564, 1927, 4033, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "31334088b6d7", "text": "In this study however, views expressed are slightly different because most patients attributed all the side effects to the use of artesunate-amodiaquine compared to other combinations.According to Asante et al., side effects such as headache, inability for some patients to control the neck and tongue were reported by patients who used ACT [5].", "entities": [{"start": 130, "end": 152, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 233, "end": 241, "label": "ADR", "text": "headache"}, {"start": 243, "end": 301, "label": "ADR", "text": "inability for some patients to control the neck and tongue"}], "input_ids": [2, 1922, 2052, 2161, 2406, 16, 9792, 3198, 2032, 5733, 2413, 2882, 2501, 2132, 6898, 2136, 1920, 4159, 2564, 1942, 1920, 2485, 1927, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 2452, 1942, 2303, 7763, 18, 3147, 1942, 15634, 4905, 1021, 2140, 1969, 18, 16, 4159, 2564, 2427, 1966, 12187, 16, 11752, 1958, 2673, 2132, 1942, 2285, 1920, 7467, 1930, 14761, 1985, 2568, 2007, 2132, 2746, 2251, 4033, 37, 25, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 4, 4, 4, 4, 4, 4, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "23d44f4fc405", "text": "Most participants (n = 21) described an ADR as a negative reaction after taking a medicine.", "entities": [], "input_ids": [2, 2501, 3003, 12, 56, 33, 2900, 13, 2910, 1925, 17645, 1966, 43, 3136, 3227, 2256, 6303, 43, 5380, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "255aa024efe1", "text": "This is the one other reason why such people who get these side effects do not report”(IDI: 26-year old female patient).Patient-related factorsPatients are usually not motivated to come back and report adverse events especially if the side effects are those already known to be associated with the drug.", "entities": [{"start": 91, "end": 118, "label": "PATIENT_DEMO", "text": "26-year old female patient"}], "input_ids": [2, 2052, 1977, 1920, 2340, 2303, 5070, 7348, 2427, 4329, 2746, 7691, 2144, 4159, 2564, 2608, 2084, 3809, 237, 12, 11407, 30, 3179, 17, 2476, 4156, 4232, 2774, 13, 18, 2774, 17, 2712, 2790, 15050, 2032, 5394, 2084, 15531, 1942, 10449, 3231, 1930, 3809, 5246, 3916, 4369, 2647, 1920, 4159, 2564, 2032, 2690, 6064, 3171, 1942, 1998, 2458, 1956, 1920, 2838, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "5631079bc24a", "text": "These were also mentioned as factors affecting effective side effects reporting in this study.The fact that patients who previously reported side effects at the health facility and could not get any help from health workers has been reported to have negative effect on adverse events reporting.", "entities": [], "input_ids": [2, 2144, 1985, 2222, 6996, 1966, 2790, 7359, 3655, 4159, 2564, 6605, 1922, 2052, 2161, 18, 1920, 2371, 1988, 2132, 2746, 3024, 2568, 4159, 2564, 2019, 1920, 2436, 8598, 1930, 2578, 2084, 7691, 2967, 4087, 2037, 2436, 7066, 2258, 2252, 2568, 1942, 2162, 3136, 2495, 1990, 5246, 3916, 6605, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "c07ffd95d794", "text": "FDA = Ghana Food and Drug Authority, MoH = Ministry of HealthResponsesGenderAgeEducationArea of livingAre you familiar with the word side effect or ADR?", "entities": [], "input_ids": [2, 11394, 33, 20685, 3959, 1930, 2838, 18791, 16, 22515, 33, 11592, 1927, 2436, 17552, 1918, 21429, 7124, 2106, 1919, 29394, 1929, 2768, 1019, 1927, 5818, 2768, 6253, 10859, 1956, 1920, 5430, 4159, 2495, 2014, 17645, 35, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "a7160f7ff54d", "text": "This is my second time of going there (health facility) and they have not told me anything on the side effects I will get when I use the drug”(IDI: 25-year old female patient).The providers confirmed that in addition to giving instructions on the dosing regimen, they are required to provide information on side effects to patients and to explain to them why it was important for them to report any side effects they experience with the drug to the nearest health facility.", "entities": [{"start": 148, "end": 174, "label": "PATIENT_DEMO", "text": "25-year old female patient"}], "input_ids": [2, 2052, 1977, 3057, 2812, 2367, 1927, 12250, 2276, 12, 2436, 8598, 13, 1930, 2611, 2162, 2084, 18313, 2142, 22491, 1990, 1920, 4159, 2564, 51, 2832, 7691, 2469, 51, 2485, 1920, 2838, 237, 12, 11407, 30, 2637, 17, 2476, 4156, 4232, 2774, 13, 18, 1920, 8044, 3982, 1988, 1922, 2459, 1942, 10382, 7186, 1990, 1920, 10654, 8607, 16, 2611, 2032, 3414, 1942, 3394, 2988, 1990, 4159, 2564, 1942, 2132, 1930, 1942, 5895, 1942, 3581, 7348, 2176, 1982, 2715, 1958, 3581, 1942, 3809, 2967, 4159, 2564, 2611, 4848, 1956, 1920, 2838, 1942, 1920, 13851, 2436, 8598, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "c885c7340dec", "text": "However, people are not being encouraged to report when they experience these side effects.", "entities": [], "input_ids": [2, 2406, 16, 4329, 2032, 2084, 3301, 15451, 1942, 3809, 2469, 2611, 4848, 2144, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "c20e7da61ee6", "text": "When the artesunate-amodiaquine was first introduced in Ghana, many patients who used it had several side effects because the components of the drug were very high [7].", "entities": [{"start": 9, "end": 31, "label": "DRUG", "text": "artesunate-amodiaquine"}], "input_ids": [2, 2469, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 1982, 2561, 6373, 1922, 20685, 16, 3086, 2132, 2746, 2251, 2176, 2430, 2980, 4159, 2564, 2882, 1920, 4178, 1927, 1920, 2838, 1985, 3345, 2149, 37, 27, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "a9731f593e54", "text": "Those who are insured, when they collect these drugs they go and share them with those who are not insured at home and such people will not be able to educate them the way they will take the drug hence they can use the drug the way they want and when they get these side effects, they turn to put the blame on the drug” (IDI: 32-year old health worker).", "entities": [{"start": 325, "end": 351, "label": "PATIENT_DEMO", "text": "32-year old health worker"}], "input_ids": [2, 2690, 2746, 2032, 27954, 16, 2469, 2611, 11946, 2144, 4195, 2611, 3611, 1930, 7948, 3581, 1956, 2690, 2746, 2032, 2084, 27954, 2019, 4502, 1930, 2427, 4329, 2832, 2084, 1998, 4236, 1942, 4066, 2010, 3581, 1920, 4222, 2611, 2832, 6132, 1920, 2838, 5566, 2611, 2112, 2485, 1920, 2838, 1920, 4222, 2611, 12914, 1930, 2469, 2611, 7691, 2144, 4159, 2564, 16, 2611, 5165, 1942, 5366, 1920, 18208, 3870, 1990, 1920, 2838, 237, 12, 11407, 30, 3323, 17, 2476, 4156, 2436, 16187, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 8, 8, 8, 8, 8, 8, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "fcab7b793605", "text": "Patients who experienced side effects were required to report to the nearest health facility, but compliance was low due to poor adverse events reporting systems [4].", "entities": [], "input_ids": [2, 2132, 2746, 6090, 4159, 2564, 1985, 3414, 1942, 3809, 1942, 1920, 13851, 2436, 8598, 16, 2308, 9135, 1982, 2330, 2810, 1942, 3930, 5246, 3916, 6605, 3771, 37, 24, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "5fdbbc32789e", "text": "Patient-related factorsPatients are usually not motivated to come back and report adverse events especially if the side effects are those already known to be associated with the drug.", "entities": [], "input_ids": [2, 2774, 17, 2712, 2790, 15050, 2032, 5394, 2084, 15531, 1942, 10449, 3231, 1930, 3809, 5246, 3916, 4369, 2647, 1920, 4159, 2564, 2032, 2690, 6064, 3171, 1942, 1998, 2458, 1956, 1920, 2838, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "e9e3c30ac78b", "text": "Ghana adopted the guidelines and started providing HAART in the public sector in 2003 at subsidized rates of $5 a month.First line first option drugs for Ghana were Zidovudine (AZT) + Lamivudine(3TC) and Nevirapine (NVP) for women of child bearing age or Efavirenz (EFV) for men and post menoupausal women.", "entities": [{"start": 165, "end": 175, "label": "DRUG", "text": "Zidovudine"}, {"start": 177, "end": 180, "label": "DRUG", "text": "AZT"}, {"start": 184, "end": 194, "label": "DRUG", "text": "Lamivudine"}, {"start": 195, "end": 198, "label": "DRUG", "text": "3TC"}, {"start": 204, "end": 214, "label": "DRUG", "text": "Nevirapine"}, {"start": 216, "end": 219, "label": "DRUG", "text": "NVP"}, {"start": 255, "end": 264, "label": "DRUG", "text": "Efavirenz"}, {"start": 266, "end": 269, "label": "DRUG", "text": "EFV"}], "input_ids": [2, 20685, 9575, 1920, 5522, 1930, 8074, 5453, 18711, 1922, 1920, 4462, 11871, 1922, 4450, 2019, 23981, 2301, 3389, 1927, 8, 25, 43, 2935, 18, 2561, 2823, 2561, 8297, 4195, 1958, 20685, 1985, 28666, 22389, 1020, 20597, 12, 28301, 13, 15, 30208, 12, 25464, 1030, 13, 1930, 27360, 11979, 12184, 12, 26513, 13, 1958, 3089, 1927, 2748, 8188, 2632, 2014, 8485, 11046, 4389, 12, 8485, 1020, 13, 1958, 3925, 1930, 2753, 3925, 4468, 4302, 7545, 3089, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 1, 0, 0, 1, 0, 1, 2, 0, 0, 1, 2, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "e430d69dd0cf", "text": "Seven of these events occurred after the first dose except for Stevens-Johnson syndrome for which the dose number was not stated.", "entities": [{"start": 63, "end": 87, "label": "ADR", "text": "Stevens-Johnson syndrome"}], "input_ids": [2, 5260, 1927, 2144, 3916, 4807, 2256, 1920, 2561, 3253, 5574, 1958, 26913, 2099, 17, 13890, 4741, 1958, 2154, 1920, 3253, 2529, 1982, 2084, 9662, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "1106f2f379bb", "text": "Also, relative to those who took J&J vaccine, the adjusted odds of serious AEFIs was 95% less among those who took AstraZeneca vaccine (aOR: 0.05, 95% CI: 0.02-0.l2, p<0.001), 85% less among those who took Moderna (aOR: 0.15, 95% CI: 0.03–0.63, p = 0.010) and less 99% among those who took Sputnik V (aOR<0.01, 95% CI: <0.01–0.07, p<0.001).Causality assessment of serious AEFIsA total of 57 AEFIs were classified as serious per the WHO’s definition of ‘serious AEFI’.", "entities": [{"start": 115, "end": 126, "label": "DRUG", "text": "AstraZeneca"}, {"start": 205, "end": 213, "label": "DRUG", "text": "Moderna"}, {"start": 290, "end": 299, "label": "DRUG", "text": "Sputnik V"}], "input_ids": [2, 2222, 16, 3338, 1942, 2690, 2746, 8659, 52, 10, 52, 5955, 16, 1920, 4967, 6408, 1927, 7433, 10194, 19894, 1036, 1982, 3002, 9, 2941, 2706, 2690, 2746, 8659, 20329, 27168, 19384, 5955, 12, 14973, 30, 20, 18, 2914, 16, 3002, 9, 3371, 30, 20, 18, 5725, 17, 20, 18, 12051, 16, 58, 32, 20, 18, 3472, 13, 16, 5140, 9, 2941, 2706, 2690, 2746, 8659, 10174, 1019, 12, 14973, 30, 20, 18, 2461, 16, 3002, 9, 3371, 30, 20, 18, 5167, 229, 20, 18, 4968, 16, 58, 33, 20, 18, 17314, 13, 1930, 2941, 4922, 9, 2706, 2690, 2746, 8659, 13113, 23705, 64, 12, 14973, 32, 20, 18, 3287, 16, 3002, 9, 3371, 30, 32, 20, 18, 3287, 229, 20, 18, 6627, 16, 58, 32, 20, 18, 3472, 13, 18, 19140, 4076, 1927, 7433, 10194, 19894, 5735, 2698, 1927, 4786, 10194, 19894, 1036, 1985, 5947, 1966, 7433, 2079, 1920, 2746, 234, 61, 6600, 1927, 233, 7433, 10194, 19894, 234, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "158f4fbe10ff", "text": "Recommendations were made for interventions to prevent and also mitigate the high levels of anaemia especially among women in the ART scale up.", "entities": [{"start": 92, "end": 99, "label": "ADR", "text": "anaemia"}], "input_ids": [2, 7578, 1985, 3915, 1958, 4984, 1942, 4625, 1930, 2222, 17710, 1920, 2149, 2428, 1927, 19682, 4369, 2706, 3089, 1922, 1920, 6903, 3536, 2353, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "bd7abecddd93", "text": "On the other hand, nausea, diarrhoea, vomiting and weakness (71 %, 65 %, 35 % and 31 %, respectively) were the four most commonly reported adverse events in exposed HCWs/HCSs administered 3TC/AZT/LPV-RTV for 28-days.", "entities": [{"start": 19, "end": 25, "label": "ADR", "text": "nausea"}, {"start": 27, "end": 36, "label": "ADR", "text": "diarrhoea"}, {"start": 38, "end": 46, "label": "ADR", "text": "vomiting"}, {"start": 51, "end": 59, "label": "ADR", "text": "weakness"}, {"start": 165, "end": 174, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 188, "end": 191, "label": "DRUG", "text": "3TC"}, {"start": 192, "end": 195, "label": "DRUG", "text": "AZT"}, {"start": 195, "end": 203, "label": "DRUG", "text": "/LPV-RTV"}], "input_ids": [2, 1990, 1920, 2303, 3897, 16, 13759, 16, 20998, 16, 13954, 1930, 12175, 12, 5858, 9, 16, 4459, 9, 16, 3259, 9, 1930, 3470, 9, 16, 2763, 13, 1985, 1920, 3006, 2501, 5384, 2568, 5246, 3916, 1922, 4616, 4387, 8327, 19, 19760, 1036, 5254, 25464, 1030, 19, 28301, 19, 8182, 1020, 17, 4341, 1020, 1958, 3158, 17, 3000, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 3, 0, 3, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 1, 2, 0, 1, 1, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "426d2244046f", "text": "The study by Currier found that in using zidovudine, men were three times more likely to reach the study endpoint than females.", "entities": [{"start": 41, "end": 51, "label": "DRUG", "text": "zidovudine"}], "input_ids": [2, 1920, 2161, 2007, 2891, 3453, 2435, 1988, 1922, 2193, 28666, 22389, 1020, 20597, 16, 3925, 1985, 2559, 3586, 2253, 3205, 1942, 4393, 1920, 2161, 11857, 2254, 5027, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "0147141bff35", "text": "The first serious ICSR was received from a 26-year-old male COVID-19 patient who was given azithromycin and hydroxychloroquine and on the same day (17th April 2020), the patient had supraventricular tachycardia, chest discomfort and abdominal pain which all started the same day the suspected drugs were administered.Concomitant drugs were started the same day as the suspected drugs were zinc, enoxaparin injection, vitamin C and ceftriaxone.", "entities": [{"start": 43, "end": 59, "label": "PATIENT_DEMO", "text": "26-year-old male"}, {"start": 90, "end": 103, "label": "DRUG", "text": "azithromycin"}, {"start": 108, "end": 126, "label": "DRUG", "text": "hydroxychloroquine"}, {"start": 181, "end": 210, "label": "ADR", "text": "supraventricular tachycardia"}, {"start": 212, "end": 228, "label": "ADR", "text": "chest discomfort"}, {"start": 233, "end": 247, "label": "ADR", "text": "abdominal pain"}, {"start": 388, "end": 393, "label": "DRUG", "text": "zinc"}, {"start": 395, "end": 405, "label": "DRUG", "text": "enoxaparin"}, {"start": 417, "end": 426, "label": "DRUG", "text": "vitamin C"}, {"start": 431, "end": 442, "label": "DRUG", "text": "ceftriaxone"}], "input_ids": [2, 1920, 2561, 7433, 13772, 1005, 1982, 4004, 2037, 43, 3179, 17, 2476, 17, 4156, 4005, 6083, 1960, 17, 2282, 2774, 2746, 1982, 3258, 28350, 1930, 8275, 11600, 1037, 15520, 1930, 1990, 1920, 2841, 3007, 12, 2752, 1963, 11071, 22656, 13, 16, 1920, 2774, 2430, 21038, 24722, 17397, 16, 8475, 15335, 1930, 6900, 3594, 2154, 2136, 8074, 1920, 2841, 3007, 1920, 9407, 4195, 1985, 5254, 18, 8537, 4195, 1985, 8074, 1920, 2841, 3007, 1966, 1920, 9407, 4195, 1985, 7997, 16, 2066, 2325, 29398, 5572, 4107, 16, 6111, 45, 1930, 28248, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 4, 0, 3, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 2, 2, 2, 0, 0, 1, 2, 0, 1, 0, -100], "source_type": "cohort_study"}
{"id": "a0615925411f", "text": "Types of AEFIs reported in GhanaThe most common AEFIs reported were headache (52.9%), pains (44.4%), pyrexia (35.1%), chills (16.7%) and injection site pain (15.6%) (Fig 1).10.1371/journal.pgph.0003770.g001Fig 1Types of AEFIs reported.Table 2 shows the AEFIs experienced by vaccine type among the vaccine recipients.10.1371/journal.pgph.0003770.t002Table 2Types of AEFIs reported by vaccine type in Ghana.CharacteristicsTotalType of vaccineFishers exactAstraZenecaJohnson and JohnsonModernaPfizerSputnik VN = 4,295N = 3,590N = 63N = 61N = 57N = 524p-valueHeadache2,274 (52.9)2,050 (57.1)23 (36.5)17 (27.9)12 (21.1)172 (32.8)<0.001Pain1,906 (44.4)1,696 (47.2)23 (36.5)26 (42.6)16 (28.1)145 (27.7)<0.001Pyrexia1,509 (35.1)1,404 (39.1)16 (25.4)11 (18.0)7 (12.3)71 (13.5)<0.001Chills716 (16.7)635 (17.7)10 (15.9)6 (9.8)5 (8.8)60 (11.5)0.001Injection site pain671 (15.6)452 (12.6)9 (14.3)13 (21.3)4 (7.0)193 (36.8)<0.001Malaise408 (9.5)399 (11.1)1 (1.6)1 (1.6)1 (1.8)6 (1.1)<0.001Dizziness363 (8.5)316 (8.8)1 (1.6)2 (3.3)4 (7.0)40 (7.6)0.13Vomiting288 (6.7)268 (7.5)3 (4.8)3 (4.9)6 (10.5)8 (1.5)<0.001Pain in extremity255 (5.9)215 (6.0)6 (9.5)12 (19.7)8 (14.0)14 (2.7)<0.001Decreased appetite/Increased appetite249 (5.8)222 (6.2)1 (1.6)4 (6.6)1 (1.8)21 (4.0)0.096Arthralgia195 (4.5)179 (5.0)2 (3.2)0 (0.0)2 (3.5)12 (2.3)0.026Swelling139 (3.2)121 (3.4)5 (7.9)6 (9.8)6 (10.5)1 (0.2)<0.001Insomnia/Somnolence139 (3.2)119 (3.3)3 (4.8)1 (1.6)1 (1.8)15 (2.9)0.8Oropharyngeal pain136 (3.2)128 (3.6)1 (1.6)0 (0.0)0 (0.0)7 (1.3)0.018Diarrhea/Hematochezia126 (2.9)110 (3.1)2 (3.2)2 (3.3)5 (8.8)7 (1.3)0.019Dyspnea118 (2.7)103 (2.9)4 (6.3)4 (6.6)6 (10.5)1 (0.2)<0.001Injection site swelling98 (2.3)86 (2.4)2 (3.2)5 (8.2)1 (1.8)4 (0.8)0.004Hyperphagia68 (1.6)62 (1.7)0 (0.0)2 (3.3)1 (1.8)3 (0.6)0.19Erythema61 (1.4)55 (1.5)1 (1.6)1 (1.6)0 (0.0)4 (0.8)0.59***Other AEFIs***685 (15.9)599 (16.7)18 (28.6)11 (18.0)13 (22.8)44 (8.4)<0.001*** Combination of all AEFIs with overall prevalence <1.0%.", "entities": [{"start": 68, "end": 76, "label": "ADR", "text": "headache"}, {"start": 101, "end": 108, "label": "ADR", "text": "pyrexia"}, {"start": 118, "end": 124, "label": "ADR", "text": "chills"}, {"start": 137, "end": 156, "label": "ADR", "text": "injection site pain"}, {"start": 453, "end": 464, "label": "DRUG", "text": "AstraZeneca"}, {"start": 464, "end": 483, "label": "DRUG", "text": "Johnson and Johnson"}, {"start": 483, "end": 490, "label": "DRUG", "text": "Moderna"}, {"start": 490, "end": 505, "label": "DRUG", "text": "PfizerSputnik V"}, {"start": 555, "end": 563, "label": "ADR", "text": "Headache"}, {"start": 701, "end": 708, "label": "ADR", "text": "Pyrexia"}, {"start": 773, "end": 779, "label": "ADR", "text": "Chills"}, {"start": 915, "end": 922, "label": "ADR", "text": "Malaise"}, {"start": 1035, "end": 1043, "label": "ADR", "text": "Vomiting"}, {"start": 1096, "end": 1113, "label": "ADR", "text": "Pain in extremity"}, {"start": 1169, "end": 1206, "label": "ADR", "text": "Decreased appetite/Increased appetite"}, {"start": 1258, "end": 1268, "label": "ADR", "text": "Arthralgia"}, {"start": 1381, "end": 1400, "label": "ADR", "text": "Insomnia/Somnolence"}, {"start": 1450, "end": 1468, "label": "ADR", "text": "Oropharyngeal pain"}, {"start": 1519, "end": 1540, "label": "ADR", "text": "Diarrhea/Hematochezia"}, {"start": 1651, "end": 1674, "label": "ADR", "text": "Injection site swelling"}, {"start": 1723, "end": 1734, "label": "ADR", "text": "Hyperphagia"}, {"start": 1782, "end": 1790, "label": "ADR", "text": "Erythema"}], "input_ids": [2, 3584, 1927, 10194, 19894, 1036, 2568, 1922, 20685, 20536, 2501, 3059, 10194, 19894, 1036, 2568, 1985, 12187, 12, 4764, 18, 29, 9, 13, 16, 3594, 1036, 12, 4044, 18, 24, 9, 13, 16, 26889, 18068, 1019, 12, 3259, 18, 21, 9, 13, 16, 7368, 11560, 1036, 12, 2641, 18, 27, 9, 13, 1930, 4107, 3200, 3594, 12, 2461, 18, 26, 9, 13, 12, 2095, 21, 13, 18, 2119, 18, 28687, 19, 5776, 18, 22534, 1023, 18, 25209, 7658, 1008, 18, 17287, 6924, 9344, 21, 13686, 1036, 1927, 10194, 19894, 1036, 2568, 18, 2545, 22, 3661, 1920, 10194, 19894, 1036, 6090, 2007, 5955, 2601, 2706, 1920, 5955, 9336, 18, 2119, 18, 28687, 19, 5776, 18, 22534, 1023, 18, 25209, 7658, 1008, 18, 28788, 11577, 22, 13686, 1036, 1927, 10194, 19894, 1036, 2568, 2007, 5955, 2601, 1922, 20685, 18, 3779, 4575, 2381, 13686, 1927, 5955, 14422, 2045, 6368, 23593, 27168, 19384, 15064, 11619, 5810, 1930, 13890, 7993, 1915, 2175, 1034, 19894, 28643, 4230, 23705, 18155, 33, 24, 16, 21102, 1022, 33, 23, 16, 24886, 1022, 33, 4968, 1022, 33, 5473, 1022, 33, 4786, 1022, 33, 4764, 24612, 17, 3113, 10611, 9044, 1028, 16, 23092, 12, 4764, 18, 29, 13, 22, 16, 27183, 12, 4786, 18, 21, 13, 3020, 12, 3480, 18, 25, 13, 2752, 12, 3225, 18, 29, 13, 2369, 12, 2900, 18, 21, 13, 15807, 12, 3323, 18, 28, 13, 32, 20, 18, 3472, 4302, 21480, 16, 3865, 1016, 12, 4044, 18, 24, 13, 21, 16, 5349, 1016, 12, 4261, 18, 22, 13, 3020, 12, 3480, 18, 25, 13, 3179, 12, 3858, 18, 26, 13, 2641, 12, 3158, 18, 21, 13, 11491, 12, 3225, 18, 27, 13, 32, 20, 18, 3472, 18425, 2783, 2126, 1009, 16, 30468, 12, 3259, 18, 21, 13, 21, 16, 27397, 12, 3886, 18, 21, 13, 2641, 12, 2637, 18, 24, 13, 2513, 12, 2654, 18, 20, 13, 27, 12, 2369, 18, 23, 13, 5858, 12, 2590, 18, 25, 13, 32, 20, 18, 3472, 19519, 11560, 1036, 9948, 1016, 12, 2641, 18, 27, 13, 4968, 1015, 12, 2752, 18, 27, 13, 2119, 12, 2461, 18, 29, 13, 26, 12, 29, 18, 28, 13, 25, 12, 28, 18, 28, 13, 3276, 12, 2513, 18, 25, 13, 20, 18, 3472, 22468, 3200, 3594, 6038, 1009, 12, 2461, 18, 26, 13, 3607, 1028, 12, 2369, 18, 26, 13, 29, 12, 2607, 18, 23, 13, 2590, 12, 2900, 18, 23, 13, 24, 12, 27, 18, 20, 13, 17392, 12, 3480, 18, 28, 13, 32, 20, 18, 3472, 9578, 5504, 4127, 30246, 12, 29, 18, 25, 13, 27749, 12, 2513, 18, 21, 13, 21, 12, 21, 18, 26, 13, 21, 12, 21, 18, 26, 13, 21, 12, 21, 18, 28, 13, 26, 12, 21, 18, 21, 13, 32, 20, 18, 3472, 7408, 18559, 8254, 5677, 1010, 12, 28, 18, 25, 13, 23242, 12, 28, 18, 28, 13, 21, 12, 21, 18, 26, 13, 22, 12, 23, 18, 23, 13, 24, 12, 27, 18, 20, 13, 3040, 12, 27, 18, 26, 13, 20, 18, 2590, 15525, 4739, 1941, 25893, 12, 26, 18, 27, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 1, 2, 2, 2, 2, 1, 2, 2, 1, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "043e6efe7321", "text": "None of those who took the Sputnik V vaccine reported a serious AEFI.", "entities": [{"start": 27, "end": 36, "label": "DRUG", "text": "Sputnik V"}], "input_ids": [2, 6046, 1927, 2690, 2746, 8659, 1920, 13113, 23705, 64, 5955, 2568, 43, 7433, 10194, 19894, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "09abde15937c", "text": "Study designThis was an analytic cross-sectional study involving secondary data analyses of COVID-19 vaccine-related AEFI reports in the safety database of the Ghana FDA, followed by analysis of causality assessment reports on all serious AEFIs.", "entities": [], "input_ids": [2, 2161, 3036, 22523, 1036, 1982, 1925, 14697, 3567, 17, 7360, 2161, 5884, 4067, 2230, 3247, 1927, 6083, 1960, 17, 2282, 5955, 17, 2712, 10194, 19894, 4710, 1922, 1920, 5407, 5039, 1927, 1920, 20685, 11394, 16, 3489, 2007, 2333, 1927, 19140, 4076, 4710, 1990, 2136, 7433, 10194, 19894, 1036, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "6f91d6fb6cb2", "text": "Information retrieved from the Safety-Watch System on each ICSRs were, the generic name of the suspected and concomitant medications, the age and sex of the patient, description of the adverse drug reaction, seriousness criteria, causality assessment, the date of administration of the suspected drug, dates of onset and stop of the ADR and the outcome of the ADR.", "entities": [], "input_ids": [2, 2988, 10931, 2037, 1920, 5407, 17, 17137, 2433, 1990, 2362, 13772, 5675, 1985, 16, 1920, 13459, 9533, 1927, 1920, 9407, 1930, 8537, 7719, 16, 1920, 2632, 1930, 3486, 1927, 1920, 2774, 16, 8418, 1927, 1920, 5246, 2838, 3227, 16, 7433, 2971, 4164, 16, 19140, 4076, 16, 1920, 5699, 1927, 4183, 1927, 1920, 9407, 2838, 16, 17483, 1927, 4727, 1930, 6875, 1927, 1920, 17645, 1930, 1920, 3924, 1927, 1920, 17645, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "2327e78cb09f", "text": "Additionally, the data on the causality assessment of serious AEFIs which was carried out by the Joint COVID-19 Vaccine Safety Review Committee was obtained on 11th December 2023.", "entities": [], "input_ids": [2, 4950, 16, 1920, 2230, 1990, 1920, 19140, 4076, 1927, 7433, 10194, 19894, 1036, 2154, 1982, 4371, 2397, 2007, 1920, 6047, 6083, 1960, 17, 2282, 5955, 5407, 3043, 6182, 1982, 2926, 1990, 2513, 1963, 9474, 17401, 1010, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "904bd06b2583", "text": "Newly reported ADRs of interest were one report each of tremor for doxycycline; scrotal pain, dyspnoea, gait disturbances and dysgeusia reported for chloroquine; and dry throat, hyperhidrosis, restlessness and micturition frequency increased for hydroxychloroquine.Description of serious ADRsOf the 53 ICSRs received during the study period, 3 (5.7%) were serious (life-threatening) and the rest nonserious.", "entities": [{"start": 56, "end": 62, "label": "ADR", "text": "tremor"}, {"start": 67, "end": 78, "label": "DRUG", "text": "doxycycline"}, {"start": 80, "end": 92, "label": "ADR", "text": "scrotal pain"}, {"start": 94, "end": 102, "label": "ADR", "text": "dyspnoea"}, {"start": 103, "end": 121, "label": "ADR", "text": "gait disturbances"}, {"start": 126, "end": 135, "label": "ADR", "text": "dysgeusia"}, {"start": 149, "end": 160, "label": "DRUG", "text": "chloroquine"}, {"start": 166, "end": 176, "label": "ADR", "text": "dry throat"}, {"start": 178, "end": 191, "label": "ADR", "text": "hyperhidrosis"}, {"start": 193, "end": 205, "label": "ADR", "text": "restlessness"}, {"start": 209, "end": 241, "label": "ADR", "text": "micturition frequency increased"}, {"start": 246, "end": 264, "label": "DRUG", "text": "hydroxychloroquine"}, {"start": 279, "end": 287, "label": "SEVERITY", "text": "serious"}, {"start": 365, "end": 380, "label": "SEVERITY", "text": "life-threatenin"}, {"start": 396, "end": 406, "label": "SEVERITY", "text": "nonserious"}], "input_ids": [2, 7471, 2568, 28863, 1927, 4501, 1985, 2340, 3809, 2362, 1927, 18388, 1958, 16647, 31, 7572, 10868, 3594, 16, 14633, 26447, 16, 11031, 12654, 1930, 3890, 2106, 24327, 1019, 2568, 1958, 20813, 31, 1930, 7143, 23555, 16, 4194, 7969, 3883, 2475, 16, 6172, 26481, 1930, 2206, 1031, 25682, 3528, 2502, 1958, 8275, 11600, 1037, 15520, 18, 8418, 1927, 7433, 28863, 4199, 1920, 4522, 13772, 5675, 4004, 2409, 1920, 2161, 3047, 16, 23, 12, 25, 18, 27, 9, 13, 1985, 7433, 12, 3308, 17, 13281, 13, 1930, 1920, 6172, 6771, 18842, 2080, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 1, 0, 3, 4, 4, 0, 3, 4, 0, 4, 4, 0, 3, 4, 4, 4, 0, 0, 1, 0, 0, 3, 4, 0, 3, 4, 4, 4, 0, 3, 4, 0, 4, 4, 4, 4, 4, 0, 1, 2, 2, 2, 0, 0, 0, 6, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 6, 6, 0, 0, 0, 0, 5, 6, 6, 0, -100], "source_type": "cohort_study"}
{"id": "b581ade0fe28", "text": "The most frequently cited symptoms were gastrointestinal in nature; vomiting, diarrhoea, and nausea followed by neurological symptoms like headache, weakness and fatigue which is similar to results from other PEP studies [15, 18, 19, 28].The study recorded three serious adverse events – all cases of hospitalisations following initiation of PEP.", "entities": [{"start": 68, "end": 76, "label": "ADR", "text": "vomiting"}, {"start": 78, "end": 87, "label": "ADR", "text": "diarrhoea"}, {"start": 93, "end": 99, "label": "ADR", "text": "nausea"}, {"start": 139, "end": 147, "label": "ADR", "text": "headache"}, {"start": 149, "end": 158, "label": "ADR", "text": "weakness"}, {"start": 162, "end": 169, "label": "ADR", "text": "fatigue"}], "input_ids": [2, 1920, 2501, 5467, 13301, 3601, 1985, 8375, 1922, 4899, 31, 13954, 16, 20998, 16, 1930, 13759, 3489, 2007, 7605, 3601, 3189, 12187, 16, 12175, 1930, 8656, 2154, 1977, 2551, 1942, 2274, 2037, 2303, 9110, 2351, 37, 2461, 16, 2654, 16, 2282, 16, 3158, 39, 18, 1920, 2161, 4562, 2559, 7433, 5246, 3916, 229, 2136, 2919, 1927, 26185, 1036, 2894, 6035, 1927, 9110, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 3, 0, 0, 0, 0, 0, 3, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "ef68c4ba299b", "text": "Whilst other causes for spontaneous abortion could not be ruled out in this patient, the occurrence of this event following intake of 3TC/AZT/LPV-RTV necessitates constant vigilance on the relationship between pregnancy outcomes and intake of the combination in order to generate enough evidence to support its continual use in pregnancy, especially during the first trimester whether used for PEP or for HAART.", "entities": [{"start": 134, "end": 137, "label": "DRUG", "text": "3TC"}, {"start": 138, "end": 141, "label": "DRUG", "text": "AZT"}, {"start": 142, "end": 149, "label": "DRUG", "text": "LPV-RTV"}], "input_ids": [2, 12126, 2303, 5092, 1958, 6242, 15660, 2578, 2084, 1998, 18074, 2397, 1922, 2052, 2774, 16, 1920, 6564, 1927, 2052, 4817, 2894, 5240, 1927, 25464, 1030, 19, 28301, 19, 8182, 1020, 17, 4341, 1020, 29777, 5168, 27097, 1990, 1920, 3303, 2192, 5284, 3685, 1930, 5240, 1927, 1920, 3921, 1922, 3238, 1942, 5655, 7867, 3095, 1942, 3373, 2496, 3884, 1923, 2485, 1922, 5284, 16, 4369, 2409, 1920, 2561, 14315, 3053, 2251, 1958, 9110, 2014, 1958, 18711, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 1, 0, 1, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "57e3befd98b0", "text": "Lactic acidosis was very rarely diagnosed and the diarrhea was not considered as part of that diagnoses.We found a surprisingly low rate of hypersensitivity rash in our patients, despite the frequent use of Nevirapine.", "entities": [{"start": 0, "end": 15, "label": "ADR", "text": "Lactic acidosis"}, {"start": 50, "end": 58, "label": "ADR", "text": "diarrhea"}, {"start": 139, "end": 162, "label": "ADR", "text": "hypersensitivity rash"}, {"start": 207, "end": 217, "label": "DRUG", "text": "Nevirapine"}], "input_ids": [2, 16562, 19051, 1982, 3345, 9671, 5377, 1930, 1920, 11904, 1982, 2084, 3311, 1966, 3131, 1927, 1988, 9455, 18, 2038, 2435, 43, 10091, 2330, 2769, 1927, 14625, 18469, 1922, 2342, 2132, 16, 4281, 1920, 6439, 2485, 1927, 27360, 11979, 12184, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 3, 4, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, -100], "source_type": "cohort_study"}
{"id": "9c8fe5f3f30f", "text": "The use of ARVs in PEP has shifted from the administration of single-drugs like zidovudine to multi-drug regimens involving dual or triple therapy with their associated issues of adverse events and adherence.", "entities": [{"start": 80, "end": 90, "label": "DRUG", "text": "zidovudine"}], "input_ids": [2, 1920, 2485, 1927, 21502, 1036, 1922, 9110, 2258, 11328, 2037, 1920, 4183, 1927, 2957, 17, 4195, 3189, 28666, 22389, 1020, 20597, 1942, 2779, 17, 2838, 9922, 5884, 7064, 2014, 10073, 3181, 1956, 2310, 2458, 6384, 1927, 5246, 3916, 1930, 7015, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "891f771dfbcd", "text": "A causality assessment was carried out on these serious AEFIs by the FDA’s Joint COVID-19 Vaccine Safety Review Committee using the procedure outlined in the World Health Organization (WHO) User Manual for the Revised WHO Classification on Causality Assessment of An Adverse Event Following Immunization (AEFI) [33].", "entities": [], "input_ids": [2, 43, 19140, 4076, 1982, 4371, 2397, 1990, 2144, 7433, 10194, 19894, 1036, 2007, 1920, 11394, 234, 61, 6047, 6083, 1960, 17, 2282, 5955, 5407, 3043, 6182, 2193, 1920, 4360, 12312, 1922, 1920, 4867, 2436, 5901, 12, 2746, 13, 8124, 8507, 1958, 1920, 10041, 2746, 5492, 1990, 19140, 4076, 1927, 1925, 5246, 4817, 2894, 10139, 12, 10194, 19894, 13, 37, 3401, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "3db9986fe5fa", "text": "Acute kidney injury occurs in 19% of patient with moderate infections and up to 51% of patients with severe sepsis with septic shock [7].", "entities": [], "input_ids": [2, 3939, 5245, 4047, 5110, 1922, 2282, 9, 1927, 2774, 1956, 5086, 5024, 1930, 2353, 1942, 4892, 9, 1927, 2132, 1956, 4010, 9019, 1956, 13927, 7418, 37, 27, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "6f1aa3760968", "text": "Although oculogyric crisis is mostly drug-induced, it can be seen in hereditary and sporadic movement disorders and disorders related to focal brain lesions.", "entities": [{"start": 9, "end": 26, "label": "ADR", "text": "oculogyric crisis"}], "input_ids": [2, 2876, 25669, 2021, 19872, 17263, 1977, 6969, 2838, 17, 2719, 16, 2176, 2112, 1998, 3945, 1922, 16321, 1930, 13088, 5829, 4414, 1930, 4414, 2712, 1942, 8083, 3068, 4518, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 3, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "574dcfdbef6c", "text": "He was started on IV 0.9% Normal saline fluids of 3L over 24hours with strict urine output monitoring, IV ciprofloxacin 400mg two times daily, tablet doxycycline 100mg twice daily was prescribed to treat the urethritis and urinary tract infection empirically as cultures were negative.", "entities": [{"start": 26, "end": 40, "label": "DRUG", "text": "Normal saline"}, {"start": 105, "end": 120, "label": "DRUG", "text": "ciprofloxacin"}, {"start": 149, "end": 162, "label": "DRUG", "text": "doxycycline"}], "input_ids": [2, 2234, 1982, 8074, 1990, 4370, 20, 18, 29, 9, 2791, 5977, 13315, 1927, 23, 1024, 2338, 18140, 3496, 1956, 9610, 6960, 6647, 5378, 16, 4370, 18502, 5805, 9759, 2288, 3586, 4692, 16, 17127, 16647, 2813, 9759, 6470, 4692, 1982, 9975, 1942, 2297, 1920, 19221, 16900, 1930, 7075, 6482, 2909, 17560, 1966, 5054, 1985, 3136, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "112f315e1812", "text": "Since Plasmodium falciparum became resistant to chloroquine, AL has been used to treat malaria.", "entities": [{"start": 48, "end": 59, "label": "DRUG", "text": "chloroquine"}, {"start": 61, "end": 63, "label": "DRUG", "text": "AL"}], "input_ids": [2, 3328, 15663, 13098, 7935, 4910, 1942, 20813, 16, 1969, 2258, 2252, 2251, 1942, 2297, 7505, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "4aae36616ffc", "text": "The spasms may be followed by emotional lability, such as restlessness, compulsive thinking, anxiety, and sensations of increased brightness or visual distortions [6].", "entities": [{"start": 4, "end": 10, "label": "ADR", "text": "spasms"}, {"start": 29, "end": 48, "label": "ADR", "text": "emotional lability"}, {"start": 58, "end": 70, "label": "ADR", "text": "restlessness"}, {"start": 71, "end": 91, "label": "ADR", "text": "compulsive thinking"}, {"start": 93, "end": 100, "label": "ADR", "text": "anxiety"}, {"start": 105, "end": 140, "label": "ADR", "text": "sensations of increased brightness"}, {"start": 143, "end": 163, "label": "ADR", "text": "visual distortions"}], "input_ids": [2, 1920, 24431, 1036, 2278, 1998, 3489, 2007, 6687, 2857, 2275, 16, 2427, 1966, 6172, 26481, 16, 21543, 14778, 16, 5592, 16, 1930, 26498, 1927, 2502, 21869, 2014, 3737, 26593, 37, 26, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 3, 4, 0, 0, 0, 0, 4, 4, 4, 0, 0, 0, 3, 4, 0, 4, 4, 0, 3, 0, 0, 4, 4, 4, 4, 0, 4, 4, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "b2efd0327c0d", "text": "Wyllie et al. reported that versive seizures can mimic oculogyric crisis, but they are associated with an alteration of consciousness and should be excluded with an electroencephalogram [9].", "entities": [], "input_ids": [2, 24622, 11560, 2621, 2140, 1969, 18, 2568, 1988, 3162, 2320, 10060, 2112, 10223, 25669, 2021, 19872, 17263, 16, 2308, 2611, 2032, 2458, 1956, 1925, 10076, 1927, 16897, 1930, 3066, 1998, 5450, 1956, 1925, 21657, 7539, 37, 29, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "f8690793da3d", "text": "On discharge after 3 weeks, his urine output was 2700mls and his renal function had normalized with a urea of 6.50mmol/L, creatinine 96umol/L, serum sodium concentration of 139mmol/L, potassium of 4.7mmol/L, Chloride of 103 mmol/L and normocytic anaemia of 9.2g/dl.", "entities": [{"start": 235, "end": 253, "label": "ADR", "text": "normocytic anaemia"}], "input_ids": [2, 1990, 7695, 2256, 23, 3625, 16, 4167, 6960, 6647, 1982, 16646, 1008, 8772, 1036, 1930, 4167, 4604, 2347, 2430, 5766, 1956, 43, 10505, 1927, 26, 18, 2761, 7445, 1945, 19, 54, 16, 9374, 4746, 1989, 1945, 19, 54, 16, 3256, 5227, 3110, 1927, 13316, 7445, 1945, 19, 54, 16, 9057, 1927, 24, 18, 27, 7445, 1945, 19, 54, 16, 9140, 1927, 9373, 6397, 19, 54, 1930, 5308, 8316, 19682, 1927, 29, 18, 16424, 19, 5268, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "7edbdc177f8c", "text": "If Local Representative or Manufacturer/ Marketing Authorization Holder receives an adverse reaction from consumer, the consumer should be advised to seek treatment, when necessary, from a healthcare provider.", "entities": [], "input_ids": [2, 2647, 3076, 5051, 2014, 6075, 19, 19584, 6799, 2466, 24879, 17561, 1925, 5246, 3227, 2037, 15863, 16, 1920, 15863, 3066, 1998, 19625, 1942, 7592, 2311, 16, 2469, 4680, 16, 2037, 43, 5841, 10989, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "67648e3c3776", "text": "Guideline on Reporting Adverse Drug Reactions FDA/SMD/GDL - 01/05 Page 19 of 28 Reporting can be done using the adverse reaction reporting form which can be obtained from the Food and Drugs Authority’s office (Appendix 1), or applicants may use their inhouse reporting forms, provided all the necessary data elements are included on the forms in a readable format and the form also complies with the CIOMS 1 format. 3.4 Reporting by MAH or Local Representative A Serious Adverse Event / Reaction (SAE) reporting form designed by the investigator / sponsor with the necessary data elements (CIOMS I format) should be used for reporting of preregistration clinical trial adverse events / reaction reports.", "entities": [], "input_ids": [2, 12954, 1990, 6605, 5246, 2838, 5298, 11394, 19, 23274, 19, 7113, 1024, 17, 3287, 19, 2914, 7178, 2282, 1927, 3158, 6605, 2112, 1998, 5404, 2193, 1920, 5246, 3227, 6605, 2386, 2154, 2112, 1998, 2926, 2037, 1920, 3959, 1930, 4195, 18791, 234, 61, 10914, 12, 9504, 21, 13, 16, 2014, 7973, 2356, 2278, 2485, 2310, 11035, 3055, 6605, 4952, 16, 3675, 2136, 1920, 4680, 2230, 5362, 2032, 3063, 1990, 1920, 4952, 1922, 43, 3603, 2115, 10387, 1930, 1920, 2386, 2222, 6581, 2062, 1956, 1920, 3371, 18995, 21, 10387, 18, 23, 18, 24, 6605, 2007, 18770, 2014, 3076, 5051, 43, 7433, 5246, 4817, 19, 3227, 12, 26426, 13, 6605, 2386, 4609, 2007, 1920, 12687, 19, 29237, 1956, 1920, 4680, 2230, 5362, 12, 3371, 18995, 51, 10387, 13, 3066, 1998, 2251, 1958, 6605, 1927, 16778, 6121, 2156, 5524, 1929, 2535, 3046, 5246, 3916, 19, 3227, 4710, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "86a77a055320", "text": "The guideline also outlines the roles and responsibilities of the Authority, the Local Representative, Healthcare Professionals Marketing Authorization Holders, and the Consumer with respect to adverse reaction reporting.", "entities": [], "input_ids": [2, 1920, 12954, 2222, 25400, 1920, 5456, 1930, 22472, 1927, 1920, 18791, 16, 1920, 3076, 5051, 16, 5841, 9229, 19584, 6799, 2466, 24879, 1036, 16, 1930, 1920, 15863, 1956, 5633, 1942, 5246, 3227, 6605, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "dfde3f184948", "text": "For Adverse Events Following Immunization, refer to the Guidelines for Surveillance on Adverse Events Following Immunization (www.fdaghana.gov.gh/img/vacine/Guidelines for Surveillance on Adverse Events Following Immunization In Ghana.pdf). 4.2 Reporting by the Local Representatives or Marketing Authorization Holder Serious adverse reaction reports received by the Local Representative or the Marketing Authorization Holder shall be submitted to the Authority within 7 calendar days.", "entities": [], "input_ids": [2, 1958, 5246, 3916, 2894, 10139, 16, 3333, 1942, 1920, 5522, 1958, 7889, 1990, 5246, 3916, 2894, 10139, 12, 6425, 18, 11394, 2509, 7241, 18, 10127, 18, 6101, 19, 2042, 1029, 19, 7017, 2053, 19, 5522, 1958, 7889, 1990, 5246, 3916, 2894, 10139, 1922, 20685, 18, 10912, 13, 18, 24, 18, 22, 6605, 2007, 1920, 3076, 18315, 2014, 19584, 6799, 2466, 24879, 7433, 5246, 3227, 4710, 4004, 2007, 1920, 3076, 5051, 2014, 1920, 19584, 6799, 2466, 24879, 22096, 1998, 10568, 1942, 1920, 18791, 2651, 27, 23948, 3000, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "5b5212f9be76", "text": "Healthcare professionals were informed about various issues, including the risk of anesthesia in individuals exposed to Pholcodine within 12 months before using neuromuscular blocking agents, the recall of Lupin's Quinapril Hydrochloride Tablets, enhanced risk management for Sodium valproate requiring changes to product information, and the detection of falsified Meronem IV in the Ghanaian market. 10,214 5,191 1,172 2,821 4,264 1,601 1,642 2,807 1,098 -42% -34% -31% ICSRs RECEIVED ICSRs ENTERED IN THE SWS ICSRs with CAUSALITY ASSESSMENT TRIAGED- TAC 2021 2022 2023 % DIFF BETWEEN 2023 & 2022", "entities": [{"start": 119, "end": 131, "label": "DRUG", "text": "Pholcodine"}, {"start": 213, "end": 237, "label": "DRUG", "text": "Quinapril Hydrochloride"}, {"start": 275, "end": 292, "label": "DRUG", "text": "Sodium valproate"}, {"start": 366, "end": 377, "label": "DRUG", "text": "Meronem IV"}], "input_ids": [2, 5841, 9229, 1985, 6210, 3001, 3425, 6384, 16, 2710, 1920, 2565, 1927, 8871, 1922, 3445, 4616, 1942, 20175, 8293, 26831, 2651, 2369, 3221, 3119, 2193, 15829, 7472, 4820, 16, 1920, 8717, 1927, 12555, 1921, 11, 61, 9012, 21358, 1970, 16675, 16576, 16, 4256, 2565, 4280, 1958, 5227, 23867, 2010, 8887, 2840, 1942, 4863, 2988, 16, 1930, 1920, 3805, 1927, 6939, 2828, 6902, 2290, 1035, 4370, 1922, 1920, 20685, 3122, 10878, 18, 2119, 16, 16708, 25, 16, 18162, 21, 16, 15807, 22, 16, 6175, 1009, 24, 16, 16710, 21, 16, 3276, 1009, 21, 16, 4723, 1028, 22, 16, 3729, 1027, 21, 16, 7102, 1025, 17, 3858, 9, 17, 3540, 9, 17, 3470, 9, 13772, 5675, 4004, 13772, 5675, 10725, 1922, 1920, 30192, 13772, 5675, 1956, 19140, 4076, 22165, 1007, 17, 9214, 17401, 1009, 17401, 1028, 17401, 1010, 9, 3228, 2192, 17401, 1010, 10, 17401, 1028, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_annual_report"}
{"id": "50aedb88ba9b", "text": "Sensitivity was also assessed by looking at the number of signals detected by the surveillance system.Predictive value positive was assessed using the number of case investigations completed and the proportion of confirmed ADRs (classified as “certain”) after causality assessment.", "entities": [], "input_ids": [2, 3802, 1982, 2222, 3683, 2007, 12300, 2019, 1920, 2529, 1927, 4771, 3330, 2007, 1920, 7889, 2433, 18, 6207, 3113, 2843, 1982, 3683, 2193, 1920, 2529, 1927, 3087, 7873, 5721, 1930, 1920, 4242, 1927, 3982, 28863, 12, 5947, 1966, 236, 4908, 237, 13, 2256, 19140, 4076, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "2b2a7e2442f1", "text": "The FDA withdrew marketing authorization for Codeine-containing cough syrups and oral ketoconazole products [15].", "entities": [{"start": 44, "end": 52, "label": "DRUG", "text": "Codeine"}, {"start": 86, "end": 98, "label": "DRUG", "text": "ketoconazole"}], "input_ids": [2, 1920, 11394, 1956, 3883, 2370, 19584, 6799, 2466, 1958, 7815, 2053, 17, 3165, 13588, 11458, 25372, 1930, 4726, 21471, 12334, 6984, 4461, 37, 2461, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "9ce66411e7f4", "text": "To improve the safety and effectiveness of medications, it is recommended to involve a variety of professionals in the causality assessment and management process [33].", "entities": [], "input_ids": [2, 1942, 3326, 1920, 5407, 1930, 6001, 1927, 7719, 16, 2176, 1977, 6198, 1942, 8156, 43, 5386, 1927, 9229, 1922, 1920, 19140, 4076, 1930, 4280, 2585, 37, 3401, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "0415c6d26dc8", "text": "Codeine-containing cough syrup was added to the essential medicines list when the national standard treatment guidelines were reviewed [26].", "entities": [{"start": 0, "end": 7, "label": "DRUG", "text": "Codeine"}], "input_ids": [2, 7815, 2053, 17, 3165, 13588, 11458, 3481, 1982, 4057, 1942, 1920, 4415, 12864, 6069, 2469, 1920, 3852, 2970, 2311, 5522, 1985, 5487, 37, 3179, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}